The Economic Times
English EditionEnglish Editionहिन्दी
| E-Paper
Search
+

80% jump in 6 months, Covid vaccine can give this stock a shot in the arm

80% jump in 6 months, Covid vaccine can give this stock a shot in the arm
80% jump in 6 months, Covid vaccine can give this stock a shot in the arm
Sputnik V vaccine, if found efficacious, can prove to be quite beneficial for DRL.

Synopsis

Opportunity to launch a vaccine would mean one-time exceptional business gain, brand boost

Mumbai: Drug major Dr Reddy’s Labs (DRL) is one Indian pharma company that has made all the right moves amid the pandemic with the latest being the tie-up with Russian Direct Investment Fund, a sovereign fund from Russia, for conducting clinical trials and distribution of the Sputnik V Covid vaccine in India. The Street cheered the company’s move, with the stock hitting a record high and closing with gains of over 4% on Thursday. The stock has
Share This Article
  • GIFT ARTICLE
  • FONT SIZE
  • SAVE
  • COMMENT

To Read the Full Story, Become an ET Prime Member

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Access the exclusive Economic Times stories, Editorial and Expert opinion

Why ?

  • Sharp Insight-rich, Indepth stories across 20+ sectors

  • Access the exclusive Economic Times stories, Editorial and Expert opinion

  • Clean experience with
    Minimal Ads
  • Comment & Engage with ET Prime community
  • Exclusive invites to Virtual Events with Industry Leaders
  • A trusted team of Journalists & Analysts who can best filter signal from noise
The Economic Times